Gene: ZNF230
Official Full Name: zinc finger protein 230provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34462 | ZNF230 Knockout cell line (HeLa) | Human | ZNF230 | 1:3~1:6 | Negative | Online Inquiry |
KO34463 | ZNF230 Knockout cell line (HCT 116) | Human | ZNF230 | 1:2~1:4 | Negative | Online Inquiry |
KO34464 | ZNF230 Knockout cell line (HEK293) | Human | ZNF230 | 1:3~1:6 | Negative | Online Inquiry |
KO34465 | ZNF230 Knockout cell line (A549) | Human | ZNF230 | 1:3~1:4 | Negative | Online Inquiry |
ZNF230 Gene Knockout Cell Lines are highly specialized biological tools generated through the precise deletion of the ZNF230 gene, which encodes a zinc finger protein involved in several cellular processes, including gene expression regulation and chromatin remodeling. These cell lines facilitate targeted investigations of gene function, enabling researchers to delve into the complex roles of ZNF230 in cellular pathways, thereby advancing our understanding of various biological phenomena and disease mechanisms.
The principal mechanism behind the functionality of ZNF230 knockout cell lines lies in the disruption of normal ZNF230 protein activity, allowing scientists to study the phenotypic consequences of its absence. By comparing the knockout cells to their wild-type counterparts, researchers can elucidate the gene's role in processes such as cell differentiation, proliferation, and apoptosis. This attribute is essential for uncovering the implications of ZNF230 in diseases like cancer or metabolic disorders, where aberrant gene regulation plays a crucial part.
The scientific importance of ZNF230 gene knockout cell lines extends to both fundamental research and clinical applications. They serve as invaluable models for drug discovery, allowing for high-throughput screening of therapeutic compounds that may target pathways involving ZNF230. Furthermore, the insights gained from these cell lines can inform personalized medicine approaches, paving the way for tailored treatment strategies based on individual genetic profiles.
What sets our ZNF230 gene knockout cell lines apart from alternatives is the precision of the gene editing technique utilized in their creation, ensuring reproducibility and reliability in experimental outcomes. Our products undergo rigorous validation to confirm the efficacy of gene knockout, along with comprehensive characterization to provide users with confidence in their applications.
For researchers and clinicians, the ZNF230 gene knockout cell lines represent a valuable asset that can deepen understanding of gene functions and diseases, thus contributing significantly to advancements in molecular biology and therapeutic development. Our commitment to producing high-quality, cutting-edge biological products stems from years of expertise in genetic research and cell line development, ensuring that our offerings align with the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.